Page last updated: 2024-10-25

diazoxide and Hypokalemic Periodic Paralysis

diazoxide has been researched along with Hypokalemic Periodic Paralysis in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Hypokalemic Periodic Paralysis: An autosomal dominant familial disorder characterized by recurrent episodes of skeletal muscle weakness associated with falls in serum potassium levels. The condition usually presents in the first or second decade of life with attacks of trunk and leg paresis during sleep or shortly after awakening. Symptoms may persist for hours to days and generally are precipitated by exercise or a meal high in carbohydrates. (Adams et al., Principles of Neurology, 6th ed, p1483)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tricarico, D1
Mele, A1
Liss, B1
Ashcroft, FM1
Lundquist, AL1
Desai, RR1
George, AL1
Conte Camerino, D1

Other Studies

1 other study available for diazoxide and Hypokalemic Periodic Paralysis

ArticleYear
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats.
    Neuromuscular disorders : NMD, 2008, Volume: 18, Issue:1

    Topics: Animals; Cromakalim; Diazoxide; Hypokalemic Periodic Paralysis; KATP Channels; Male; Membrane Potent

2008